Back to Results
First PageMeta Content
Angiotensin II receptor antagonists / Novartis / Valsartan / Tegaserod / Pharmaceutical industry / False Claims Act / Amlodipine/valsartan / Oxcarbazepine / Qui tam / Chemistry / Organic chemistry / Pharmacology


Document Date: 2012-02-28 15:37:19

Open Document

File Size: 84,50 KB

Share Result on Facebook

City

East Hanover / /

Company

Novartis Pharmaceuticals Corporation / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / /

Facility

United States District Court / /

IndustryTerm

pharmaceutical manufacturer / treatment of bipolar disorder / /

MedicalCondition

partial seizures / pain / epilepsy / bipolar disorder / /

Organization

federal government / Food and Drug Administration / National Association of Medicaid Fraud Control Units / United States District Court / United States Department of Health and Human Services / Team / office of the Inspector General / office of the United States / /

Person

Trileptal / /

Position

Attorney / speaker / /

Product

Diovan / Zelnorm / Sandostatin / Exforge / Trileptal / Tekturna / LABEL DRUG / Food / /

ProvinceOrState

Ohio / Pennsylvania / Delaware / Florida / /

SocialTag